Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D006084:Graft Rejection; D006085:Graft Survival; D015808:HLA-DR6 Antigen; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use*; D011897:Random Allocation; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors
D000961:Antilymphocyte Serum; D015808:HLA-DR6 Antigen; D000949:Histocompatibility Antigens Class II; D011241:Prednisone